newsfilter
← Latest News
Business Wire·

Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference

  • Coya Therapeutics, Inc. will participate in a panel discussion at Chardan's 10th Annual Healthcare Conference in New York on October 20.
  • The panel titled "Targeting Neurodegenerative & Neuromuscular Disease: ALS, DMD, Alzheimer's & Parkinson's" begins at 2:00 PM ET.
  • Keay Nakae serves as the moderator, while Fred Grossman, DO, President & Chief Medical Officer of Coya, represents the company.
  • Coya's management team will be available for one-on-one meetings during the event.
  • Coya is a clinical-stage biotechnology firm based in Houston, TX, focused on enhancing regulatory T-cell (Treg) function to address neuroinflammation.
  • The company's pipeline includes Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.